Literature DB >> 11369616

Epidermal growth factor-like ligands and erbB genes in the peri-implantation rabbit uterus and blastocyst.

T Klonisch1, P Wolf, S Hombach-Klonisch, S Vogt, A Kuechenhoff, F Tetens, B Fischer.   

Abstract

Molecular cloning of the partial cDNA coding sequences of the four erbB receptors and the epidermal growth factor (EGF)-like ligands EGF, transforming growth factor alpha (TGF), and heparin-binding EGF (HB-EGF) has provided the basis for a comprehensive analysis of the spatiotemporal expression pattern of the EGF receptor/ligand system during the peri-implantation period in the rabbit. Employing nonradioactive in situ hybridization and immunolocalization, we observed differential expression of erbB1-erbB3 within the trophectoderm of the blastocyst. ErbB1 was strongly expressed in the cytotrophoblast but was downregulated upon syncytium formation. ErbB3 was a product of both the cyto- and syncytiotrophoblast. Despite the expression of erbB2 mRNA, the trophectoderm was devoid of immunoreactive ErbB2. ErbB4 gene activity was exclusively detected in the trophoblast at midpregnancy. The luminal and glandular epithelium and stroma of the nonpregnant, pseudopregnant, and pregnant rabbit uterus at Day 6 of gestation also expressed ErbB1-ErbB3. In the peri-implantation period, gene activities of erbB1-erbB3 were upregulated upon decidualization. At the site of implantation, uterine luminal epithelial cells apposing the preimplantation blastocyst displayed a distinct membrane immunolocalization of ErbB2, identifying the uterine epithelium as target for EGF, TGFalpha, and HB-EGF derived from both the embryonic trophectoderm and the uterine epithelium. In the luminal epithelium at the antimesometrial uterine site, HB-EGF gene activity was upregulated at the time of blastocyst attachment, but this upregulation was not reflected in an increase in immunoreactive HB-EGF. The detection of tyrosine phosphorylated ErbB2 in the rabbit placenta indicated the presence of a functional ErbB/EGF-like system in the pregnant rabbit uterus. This study provides strong evidence for a role of the ErbB/EGF-like system in embryo/maternal interactions during the peri-implantation period in the rabbit.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369616     DOI: 10.1095/biolreprod64.6.1835

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

1.  The profile of the epidermal growth factor system in rat endometrium during postpartum involution period.

Authors:  Emel Alan; Narin Liman; Hakan Sağsöz
Journal:  Vet Res Commun       Date:  2015-03-11       Impact factor: 2.459

2.  Expression of SWAP-70 in the uterus and feto-maternal interface during embryonic implantation and pregnancy in the rhesus monkey (Macaca mulatta).

Authors:  Jing Liu; Ya-Yuan Fu; Xiao-Yang Sun; Fei-Xue Li; Yu-Xia Li; Yan-Ling Wang
Journal:  Histochem Cell Biol       Date:  2006-06-20       Impact factor: 4.304

3.  Decreased growth factor expression through RNA interference inhibits development of mouse preimplantation embryos.

Authors:  Tedla D Dadi; Ming W Li; K C Kent Lloyd
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

Review 4.  HB-EGF: a unique mediator of embryo-uterine interactions during implantation.

Authors:  Hyunjung Jade Lim; S K Dey
Journal:  Exp Cell Res       Date:  2008-08-03       Impact factor: 3.905

Review 5.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

6.  Embryo implantation is closely associated with dynamic expression of proprotein convertase 5/6 in the rabbit uterus.

Authors:  Peter K Nicholls; Zhaogui Sun; Sophea Heng; Ying Li; Jian Wang; Guiying Nie
Journal:  Reprod Biol Endocrinol       Date:  2011-04-06       Impact factor: 5.211

7.  Evolutionary transcriptomics implicates HAND2 in the origins of implantation and regulation of gestation length.

Authors:  Mirna Marinić; Katelyn Mika; Sravanthi Chigurupati; Vincent J Lynch
Journal:  Elife       Date:  2021-02-01       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.